Select Page
Zoi-Dorothea Pana
Lecturer, Pediatrics
Z.Pana@euc.ac.cy
22559648
School of Medicine
Medicine
Academic Qualifications
Qualification Year Awarding Institution Department
Post Doc Fellowship in Infectious Disease 2016-2017 Johns Hopkins Hospital (Baltimore, USA) Hospital Epidemiology and Infection Control (HEIC) Department, Division of Infectious Diseases Pediatric Infectious Diseases Department Division of Infectious Diseases, Clinical Microbiology Department Division of Pathology,
1st  Master Degree (MSc)  Medical Epidemiology and Methodology, Certification of Master Degree  in  Clinical Epidemiology and Statistics 2006-2008 Medical  Faculty, Aristotle University (Thessaloniki, Greece) Medical  Faculty, Aristotle University
2nd  Master Degree (MSc) Nanotechnology and Nanosciences   Certification of Master Degree in Nanosciences 2010-2014 Faculty of Physics, Aristotle University (Thessaloniki, Greece)  Aristotle University
PhD Diploma (PhD Degree) Dissertation: “Mannose Binding Lectin and Ficolin 2 gene polymorphisms and infection susceptibility in children with acute lymphoblastic leukemia.” Certification of PhD Degree in Genetic Immunodeficiencies and Infectious Diseases In Paediatrics 2009-2012 Medical Faculty, Aristotle University Medical  Faculty, Aristotle University
Employment History
Period of employment Employer Location Position
To
present Greek Ministry of Health (Athens, Greece the Greek Health Technology Assessment Committee (HTA) Scientific Member
present Aristotle University of Thessaloniki Clinical Pharmacology Research collaborator
2017 Johns Hopkins Hospital (Baltimore, USA) Hospital Epidemiology and Infection Control (HEIC) Department, Division of Infectious Diseases, Pediatric Infectious Diseases Department Division of Infectious Diseases, Post doc fellow
Publications
Year Title Other authors Journal and Publisher / Conference Vol. Pages
2014 ESCMID & ECMM Joint Guidelines on Diagnosis and Management of Hyalohyphomycosis: Fusarium spp, Scedosporium spp Tortorano, A; Richardson, M; Roilides, Emmanuel; van Diepeningen, Anne; Caira, Morena; Muñoz, patricia; Johnson, Elizabeth; Meletiadis, Joseph; Pana, Zoi-Dorothea; et al. Clin Microbiol Infect. 20 Suppl 3 27-46
2014 Mannose Binding Lectin and Ficolin-2 polymorphisms are associated with increased risk for bacterial infections in children with B acute  lymphoblastic leukemia. Pana ZD, Samarah F, Papi R,  et  al. Pediatr Blood Cancer. 61(6) 1017-22.
2017 Chromoblastomycosis: An orphan disease Flavio Queiroz-Telles, Sybren de Hoog, Daniel Wagner Santos, Claudio Salgado, Vania Vicente, Alexandro Bonifaz Bonifaz, Emmanuel Roilides, Liyan Xi, Conceição  Silva, Moises Batista da Silva, ZD Pana, et al.. Clin Microbiol Rev. 30(1) 233-276.
2016 Invasive Mucormycosis in Children: An Epidemiologic Study in European and Non-European Countries Based on Two Registries" Pana ZD, Danila Seidel, Anna Skiada, Andreas H. Groll, Georgios Petrikkos, Oliver A. Cornely, Emmanuel Roilides  BMC Infect Dis. 16(1) 667
2017 Recognition and clinical presentation of invasive fungal disease in neonates and children. King J, Pana ZD, Lehrnbecher T, et al. Invited supplement at the Journal of pediatric Infectious Diseases Journal
2018 National Healthcare Safety Network laboratory-identified clostridium difficile event reporting: A need for diagnostic stewardship. Rock C, Pana Z, et al. CDC Prevention Epicenters Program. Am J Infect Control. pii: S0196-6553(17) 31176-8.
2012 Candidaemia in a European Paediatric University Hospital: a 10-year observational study. Tragiannidis A, Fegeler W, Rellensmann G, Debus V, Müller V, Hoernig-Franz I, Siam K, Pana ZD, Jürgens H, Groll AH. Clin Microbiol Infect. 18(2) 27- 30.
2017 The Epidemiology of Invasive Fungal Disease in Children. Pana ZD, Roilides E, Warris A, et al. J Pediatric Infect Dis Soc. 6(suppl1) 3-11.
2018 Treatment of extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBLs) infections: what have we learned until now? Pana ZD, Zaoutis TE F1000Res- F1000 Faculty Reiew 7. 1347.
  2018 Toxoplasmosis in Transplant Recipients, Europe, 2010-2014 Robert-Gangneux F, Meroni V, Dupont D, Botterel F, Garcia JMA, Brenier-Pinchart MP, Accoceberry I, Akan H, Abbate I, Boggian K, Bruschi F, Carratalà J, David M, Drgona L, Djurković-Djaković O, Farinas MC, Genco F, Gkrania-Klotsas E, Groll AH, Guy E, Hirzel C, Khanna N, Kurt Ö, Junie LM, Lazzarotto T, Len O, Mueller NJ, Munoz P, Pana ZD, et al. Emerg Infect Dis. 24(8) 1497-1504.
Exhibitions
Date Topic International / Local Location* Role in Exhibition
2015 37  Invasive Candidiasis in children with organic aciduria TIMM 2015 Copenhagen Speaker
2013       Fungal Endocarditis in Neonates: Systematic Review of 70 Cases. Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) Denver, Colorado, USA Speaker
2015 3    MUCORMYCOSIS IN CHILDREN:  A PROSPECTIVE, EPIDEMIOLOGIC STUDY IN EUROPEAN AND NON-EUROPEAN COUNTRIES (ECMM/ISHAM WG & Fungiscope) 55rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) September 18 – 21, 2015. San Diego, CA Speaker
2015 .      Voriconazole Prophylaxis in Children with Malignancies: A Nationwide Study. 55rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) September 18 – 21, 2015. San Diego, CA Speaker
2016       Enhanced Activity of Carbon Nanotubes-Amphotericin B Conjugates Against Mature Biofilms of Candida albicans 56rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) (June 16–20, 2016, Boston, MA). Speaker
2017 Preventability of MRSA Lab ID Events: A Single Institution Experience SHEA Spring Conference. St. Louis, MO from March 29 - 31, 2017 Speaker
2017 Curvularia spp. Pseudo-outbreak during Construction Period at a Tertiary Care Hospital SHEA Spring Conference. St. Louis, MO from March 29 - 31, 2017 Speaker
Research Projects
Date Title Funded by Project Role*
2011-2014) NEOMERO 1 clinical study (European Clinical trial) Efficacy, Pharmacokinetics and safety of meropenem in infants below 90 days of age with clinical or confirmed late onset sepsis: A European multicenter randomized phase III trial. PENTA ID, EU Role: Co-Investigator/Study Coordinator
2016- present Research: Euro Candy study: (European study) ongoing epidemiology of invasive fungal infections  in neonates and children across Europe, including information on antifungal prescribing and resistance The European Pediatric Mycology Network (EPMyN, PENTA-ID ) Role: Study Design, Co-investigator
2012-2014 NEOMERO 2 clinical study ( (European Clinical trial) Efficacy, Pharmacokinetics and safety of meropenem in infants below 90 days of age with clinical or confirmed late onset Meningitis: A European multicenter randomized phase III trial. PENTA ID, EU Role: Co-Investigator
2011-present ΙPFN/   BIOPIC   research   study  (International   clinical   study) International Pediatric Fungal Network on diagnosis and treatment of fungal infections International pediatric fungal network ΙPFN Role: Co-Investigator and Data review committee
(2018-now) Research: Mycobiome study: (European study) ongoing Multi-centre study to evaluate the dynamics changes of mycobiome in children with leukemia under exposure to chemotherapy and/or antimicrobials/antifungals. European Society of pediatric infectious diseases (ESPID) Role: Principal Investigator
(2011-2016): A8851008 clinical study (International clinical trial) A prospective open label study to assess the pharmacokinetics, safety & efficacy of anidilafungin when used  to treat children with invasive candidiasis, including candidemia Pfizer Role: Co-  Investigator/Study Coordinator
(2011-2015) Research: Voriproph study:(National study) Voriconazole prophylaxis in children with malignancies. A nationwide study in Greece (2015). Pfizer Role: Study Coordinator
(2018-now) Research: NEOVANC study:) (European study) ongoing Multi-centre, Randomised, Open Label, Phase IIb Study to Compare the Efficacy, Safety and Pharmacokinetics (PK) of an Optimised Dosing to a Standard Dosing Regimen of Vancomycin in Neonates and Infants Aged ≤ 90 Days With Late Onset Bacterial Sepsis Known or Suspected to be Caused by Gram- positive Microorganisms. PENTA ID, EU Role: Sub-investigator
2016 Research: CIR00021356/ IRB00081996 (2016): (clinical study) Using human factors approach to discover new strategies to improve environmental cleaning within the hospital setting. JHH (Johns Hopkins Hospital) Role: Co-Investigator
2016 Research: CIR00021562/ IRB00038005 (2016): (clinical study) Clinical Outcomes of ESBL Enterobacteriaceae. JHH (Johns Hopkins Hospital) Role: Co-Investigator
Academic Consulting Services/Councils/Boards/Editorial Committees
Period Organization Title of Position or Service Key Activities
(2017-now) ( 2010-now) European Society of Pediatric Infectious Diseases (ESPID) Committee of Scientific Affairs and Awards Young Member of the European Society of Pediatric Infectious Diseases ESPID Review and assess research EU proposals in PID area
2016 Member of the “women in ID” association at the Johns Hopkins Hospital Member of the post-doc fellows’ association at the Johns Hopkins Hospital (2016-till now) Scientific Member- Consultant
(2011-now) (2013-now) European Society of Clinical Microbiology and Infectious Diseases ESCMID Member of the ESCMID Study Group for Infections in Compromised Hosts – ESGICH Scientific Member- Consultant
(2016-now) (2015-now) American Society of Microbiology Member of the ASM Member of the Infectious Diseases Society of America IDSA Scientific Member-
(2018-till now) Greek Ministry  of Health Scientific Member of the Greek Health Technology Assessment Committee (HTA) evaluation of properties, effects and/or impacts of health technology with emphasis on medicinal drugs in Greece and is considered as the multi tasked application of knowledge and skills to inform the formulation of safe, effective health policies that are simultaneously patient focused and seek to achieve best value in Greece.
Awards/International Recognition
Date Title Awarded by:
(2017-2019) European Society of Pediatric Infectious Diseases (ESPID) Fellowship Award. A fellowship award from the European Society of pediatric infectious diseases (ESPID) to distinguished physicians from European Union (EU) with interest in Pediatric Infectious Diseases (PIDs) European Society of Pediatric Infectious Diseases (ESPID)
(2017) DOM Research Retreat Meeting Award (Johns Hopkins Hospital). Among the three finalists for the W. Leigh Thomson excellence award for clinical research fellows at the DOM Research Retreat Meeting Johns Hopkins Hospital
(2010 2011) European Society of Pediatric Infectious Diseases (ESPID) Small Grant Award. Project proposal “Mannose Binding Lectin and Ficolin-2 polymorphisms are associated with increased risk for bacterial infections in children with B acute lymphoblastic leukemia.” European Society of Pediatric Infectious Diseases (ESPID)
(2013) Georgios K. Daikos Award. Award from the Hellenic Society for Infectious Diseases for the best PhD Thesis in Greece, in the infectious diseases area, with the title: Mannose Binding Lectin and Ficolin-2 polymorphisms are associated with increased risk for bacterial infections in children with B acute lymphoblastic leukemia.” Hellenic Society for Infectious Diseases
(2014) LIBRA Excellence in Science Fellowship Award. A scholarship from LIBRA Company to distinguished medical scientists from Greece to financially support one year of salary in order to conduct research-post doc fellowship at Johns Hopkins Hospital LIBRA Company
2015 ICAAC -Postdoctoral Travel fellowship. To attend and present research work at the ICAAC meeting 2015 (San Diego, California USA) ICAAC
Other Achievements